|
1
|
Colter DC, Sekiya I and Prockop DJ:
Identification of a subpopulation of rapidly self-renewing and
multipotential adult stem cells in colonies of human marrow stromal
cells. Proc Natl Acad Sci USA. 98:7841–7855. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Phinney DG and Prockop DJ: Concise review:
Mesenchymal stem/multipotent stromal cells: The state of
transdifferentiation and modes of tissue repair-current views. Stem
Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bassi E, Aita CA and Câmara NO: Immune
regulatory properties of multipotent mesenchymal stromal cells:
Where do we stand? World J Stem Cells. 3:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han KH, Ro H, Hong JH, Lee EM, Cho B, Yeom
HJ, Kim MG, Oh KH, Ahn C and Yang J: Immunosuppressive mechanisms
of embryonic stem cells and mesenchymal stem cells in alloimmune
response. Transpl Immunol. 25:7–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Poll D, Parekkadan B, Cho CH,
Berthiaume F, Nahmias Y, Tilles AW and Yarmuch ML: Mesenchymal stem
cell-derived molecules directly modulate hepatocellular death and
regeneration in vitro and in vivo. Hepatology. 47:1634–1643. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Le Blanc K, Frassoni F, Ball L, Locatelli
F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger
M, et al: Mesenchymal stem cells for treatment of
steroid-resistant, severe, acute graft-versus-host disease: A phase
II study. Lancet. 371:1579–1586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vojtassak J, Danisovic L, Kubes M, Bakos
D, Jarabek L, Ulicná M and Blasko M: Autologous biograft and
mesenchymal stem cells in treatment of the diabetic foot. Neuro
Endocrinol Lett. 27 Suppl 2:134–137. 2006.PubMed/NCBI
|
|
8
|
Ankrum J and Karp JM: Mesenchymal stem
cell therapy: Two steps forward, one step back. Tends Mol Med.
16:203–209. 2010. View Article : Google Scholar
|
|
9
|
Nauta AJ, Westerhuis G, Kruisselbrink AB,
Lurvink EG, Willemze R and Fibbe WE: Donor-derived mesenchymal stem
cells are immunogenic in an allogeneic host and stimulate donor
graft rejection in a nonmyeloablative setting. Blood.
108:2114–2120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spaggiari GM, Capobianco A, Becchetti S,
Mingari MC and Moretta L: Mesenchymal stem cell-natural killer cell
interactions: Evidence that activated NK cells are capable of
killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell
proliferation. Blood. 107:1484–1490. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pasare C and Medzhitov R: Toll-like
receptors: Linking innate and adaptive immunity. Adv Exp Med Biol.
560:11–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beutler B, Hoebe K, Du X and Ulevitch RJ:
How we detect microbes and respond to them: The Toll-like receptors
and their transducers. J Leukoc Biol. 74:479–485. 2004. View Article : Google Scholar
|
|
14
|
DelaRosa O and Lombardo E: Modulation of
adult mesenchymal stem cells activity by toll-like receptors:
Implications on therapeutic potential. Mediators Inflamm.
2010:8656012010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lombardo E, Delarosa O, Mancheño-Corvo P,
Menta R, Ramírez C and Büscher D: Toll-like receptor-mediated
signaling in human adipose-derived stem cells: Implications for
immunogenicity and immunosuppressive potential. Tissue Eng Part A.
15:1579–1589. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liotta F, Angeli R, Cosmi L, Filì L,
Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, et
al: Toll-like receptors 3 and 4 are expressed by human bone
marrow-derived mesenchymal stem cells and can inhibit their T-cell
modulatory activity by impairing notch signaling. Stem Cells.
26:279–289. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tomchuck SL, Zwezdaryk KJ, Coffelt SB,
Waterman RS, Danka ES and Scandurro AB: Toll-like receptors on
human mesenchymal stem cells drive their migration and
immunomodulating responses. Stem Cells. 26:99–107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bianco P, Robey PG and Simmons PJ:
Mesenchymal stem cells: Revisiting history, concepts, and assays.
Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karussis D, Karageorgiou C,
Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte
JW, Petrou P, Ben-Hur T, Abramsky O and Slavin S: Safety and
immunological effects of mesenchymal stem cell transplantation in
patients with multiple sclerosis and amyotrophic lateral sclerosis.
Arch Neurol. 67:1187–1194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Allison M: Genzyme backs Osiris, despite
prochymal flop. Nat Biotechnol. 27:966–967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y and Lin F: Mesenchymal stem cells are
injured by complement after their contact with serum. Blood.
120:3436–3443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hoebe K, Janssen E and Beutler B: The
interface between innate and adaptive immunity. Nat Immunol.
5:971–974. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kambris Z, Hoffmann JA, Imler JL and
Capovilla M: Tissue and stage-specific expression of the Tolls in
Drosophila embryos. Gene Expr Patterns. 2:311–317. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beutler B, Jiang Z, Georgel P, Crozat K,
Croker B, Rutschmann S, Du X and Hoebe K: Genetic analysis of host
resistance: Toll-like receptor signaling and immunity at large.
Annu Rev Immunol. 24:353–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferrandon D, Imler JL and Hoffmann JA:
Sensinginfection in Drosophila: Toll and beyond. Semin Immunol.
16:43–53. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gangloff M, Weber AN, Gibbard RJ and Gay
NJ: Evolutionary relationships, but functional differences, between
the Drosophila and human Toll-like receptor families. Biochem Soc
Trans. 31:659–663. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schon MP and Schön M: TLR7 and TLR8 as
targets in cancer therapy. Oncogene. 27:190–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamamoto-Furusho JK and Podolsky DK:
Innate immunity in inflammatory bowel disease. World J
Gastroenterol. 13:5577–5580. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang XP, Sun Z, Miyagi Y, Kinkaid H
McDonald, Zhang L, Weisel RD and Li RK: Differentiation of
allogeneic mesenchymal stem cells induces immunogenicity and limits
their long-term benefits for myocardial repair. Circulation.
122:2419–2429. 2010. View Article : Google Scholar : PubMed/NCBI
|
